上海医药：缩宫素注射液及醋酸奥曲肽注射液获得菲律宾药品注册证书

Core Viewpoint - Shanghai Pharmaceuticals (601607.SH) announced that its subsidiary, Shanghai Pharmaceutical First Biochemical Co., Ltd., received drug registration certificates from the Philippines Food and Drug Administration for the oxytocin injection and octreotide acetate injection, allowing these drugs to be marketed [1] Group 1: Product Approvals - The oxytocin injection is primarily used for induction of labor, postpartum hemorrhage, and assessing placental reserve function [1] - The octreotide acetate injection is used for treating acromegaly, alleviating symptoms related to functional gastrointestinal endocrine tumors, preventing postoperative complications from pancreatic surgery, and managing esophageal variceal bleeding [1]